The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...
Editas strengthened its balance sheet by raising $17.8 million through its ATM (at-the-market) offering in the third quarter ...
AI and RNA genetic-medicine company Genetic Leap is teaming up with pharma giant Eli Lilly to develop genetic medicine therapeutics. According to the two companies, the partnership expands on a pilot ...
Phlow’s bold mission to restore U.S. pharmaceutical independence shows that resilience can be both operational and a moral ...
Blueprint Medicines became the first company to offer a precision treatment for ISM, making it one of Fast Company’s Most Innovative Companies in medicines and therapeutics. Indolent Systemic ...
A few months back, Barron’s featured an intriguing pharmaceutical company that goes by the name The Medicines Company (NASDAQ:MDCO). This stock is said to have strong catalysts that could lift the ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) will host a conference call and webcast for investors on Saturday, May 18, 2019, at 5:30 p.m. EDT. During the call, the Company’s ...
Cabinet Health, a company that makes drugs and refillable glass bottles with the aim of eliminating single-use plastics from medicine and whose founders are based in Williamsburg, has raised a $17 ...
Returning investor Arboretum Ventures, joined by Hatteras Venture Partners, to fuel Boomerang Medical’s accelerated clinical and regulatory progress. MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–November 1, ...
Winston-Salem is continues to grow its reputation as a biotech hub as it attracts Humabiologics, a Phoenix-based regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback